We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · February 15, 2021

Minority Cystic Fibrosis Patients Less Likely Eligible for CFTR Modulators Based on CFTR Genotype

Pediatric Pulmonology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Pediatric Pulmonology
Cystic Fibrosis Patients of Minority Race and Ethnicity Less Likely Eligible for CFTR Modulators Based on CFTR Genotype
Pediatr. Pulmonol. 2021 Jan 20;[EPub Ahead of Print], ME McGarry, SA McColley

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading